Isabel Mok

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Steven H. Lin, Brian P. Hobbs, Vivek Verma et al. · Journal of Clinical Oncology · 2020 · 262 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.

David R. Fogelman, Robert A. Wolff, Scott Kopetz et al. · PubMed · 2011 · 93 citations

Medicine, Oncology, Pharmacology +17

First in human phase I study of BSI-201, a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in subjects with advanced solid tumors

Scott Kopetz, Monica Mita, Isabel Mok et al. · Journal of Clinical Oncology · 2008 · 61 citations

Medicine, Oncology, Pharmacology +13

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Steven H. Lin, Daniel L. Clay, Luyang Yao et al. · Journal of Thoracic Oncology · 2018 · 26 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II trial combining atezolizumab concurrently with chemoradiation therapy in locally advanced non-small cell lung cancer.

Steven H. Lin, Yan Lin, Isabel Mok et al. · Journal of Clinical Oncology · 2019 · 16 citations

Medicine, Oncology, Pharmacotherapy +17